Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial

Peter Selby, Sarwar Hussain, Sabrina Voci, Laurie Zawertailo, Peter Selby, Sarwar Hussain, Sabrina Voci, Laurie Zawertailo

Abstract

Background: Varenicline and bupropion, efficacious smoking cessation medications, have had suboptimal impact due to barriers at the patient, practitioner and system level. This study explored the feasibility of a web-assisted tobacco intervention offering free prescription smoking cessation medication by mail if the smoker visited a physician for authorization.

Methods: Adult Ontarians, smoking at least 10 cigarettes daily, intending to quit within 30 days, with no contraindications to bupropion or varenicline were eligible. After an online assessment, eligible participants received an electronic personalized printable prescription form for a 12-week course of varenicline or bupropion to bring to a physician within 3 weeks for authorization, if appropriate. The physician's office faxed prescriptions to an online pharmacy that couriered medication to the patient following medication counselling by telephone. Weekly motivational emails were sent during treatment. Participants were asked to complete follow-up questionnaires online at 7, 11, 15 and 41 weeks after enrollment.

Results: In total, 1214 individuals submitted an online assessment from April to September 2010 and 73.6 % (95 % confidence interval (CI) = 71.1-76.1 %; n = 893) were eligible. At least 65.8 % (95 % CI = 62.7-68.9 %; n = 588) of eligible participants subsequently visited a physician and 58.7 % (95 % CI = 55.5-61.9 %; n = 524) received medication (50.6 % varenicline [n = 265] and 49.4 % bupropion [n = 259]). Reasons for not filling a prescription were failure to visit a physician (80.1 %; 95 % CI = 73.8-86.5 %; n = 121), physician not prescribing the medication (15.9 %; 95 % CI = 10.1-21.7 %; n = 24) or other reasons (4.0 %; 95 % CI = 0.9-7.1 %; n = 6). Follow-up response rate was 66.7 % (95 % CI = 63.7-69.8 %; n = 596). Minimal issues were encountered with printing the prescription or medication delivery.

Conclusions: This study establishes the feasibility of using the Internet and free medication to enable smokers to engage physicians to treat this addiction. Implementation of this intervention can be scaled up by leveraging existing healthcare systems to treat smokers on a population level. Further evaluation in a randomized controlled trial is necessary.

Trial registration: ClinicalTrials.gov Identifier NCT01023659.

Figures

Fig. 1
Fig. 1
Flow chart of recruitment and follow-up. EOT end of treatment (15 weeks after study enrollment)

References

    1. World Health Organization . WHO report on the global tobacco epidemic, 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva, Switzerland: World Health Organization; 2013.
    1. Centers for Disease Control and Prevention. Smoking and tobacco use: fast facts. Atlanta, GA: Centers for Disease Control and Prevention. 2014. . Accessed May 20 2014.
    1. Centers for Disease Control and Prevention Quitting smoking among adults—United States, 2001–2010. Morb Mortal Wkly Rep. 2011;60(44):1513–9.
    1. Reid JL, Hammond D, Rynard VL, Burkhalter R. Tobacco use in Canada: patterns and trends, 2014 edition. Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo; 2014.
    1. Marques-Vidal P, Melich-Cerveira J, Paccaud F, Waeber G, Vollenweider P, Cornuz J. Prevalence and factors associated with difficulty and intention to quit smoking in Switzerland. BMC Public Health. 2011;11(1):227. doi: 10.1186/1471-2458-11-227.
    1. Zhu S-H, Lee M, Zhuang Y-L, Gamst A, Wolfson T. Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control. 2012;21(2):110–8. doi: 10.1136/tobaccocontrol-2011-050371.
    1. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29–38. doi: 10.1111/j.1360-0443.2004.00540.x.
    1. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta‐analysis. Cochrane Database Syst Rev. 2013;5:CD009329.
    1. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev. 2008;17(6):535–44. doi: 10.1097/CEJ.0b013e3282f75e48.
    1. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102–11. doi: 10.1016/j.amepre.2007.09.033.
    1. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8):1405–13. doi: 10.1080/14622200802239280.
    1. Hammond D, McDonald PW, Fong GT, Borland R. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction. 2004;99(8):1042–8. doi: 10.1111/j.1360-0443.2004.00754.x.
    1. Reda AA, Kotz D, Evers S, van Schayck CP. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2012;6:CD004305.
    1. Selby P, Brosky G, Oh P, Raymond V, Arteaga C, Ranger S. A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION) BMC Public Health. 2014;14(1):433. doi: 10.1186/1471-2458-14-433.
    1. Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119–22. doi: 10.1016/j.amepre.2004.09.007.
    1. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update—clinical practice guideline. 2008. Rockville, MD: Public Health Service, US Department of Health and Human Services; 2008.
    1. CAN-ADAPTT . Canadian smoking cessation clinical practice guideline. Toronto, Canada: Centre for Addiction and Mental Health; 2011.
    1. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39:II2–II45. doi: 10.1097/00005650-200108002-00002.
    1. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J. 1998;317(7156):465–8. doi: 10.1136/bmj.317.7156.465.
    1. Carson KV, Verbiest ME, Crone MR, Brinn MP, Esterman AJ, Assendelft WJ, et al. Training health professionals in smoking cessation. Cochrane Database Syst Rev. 2012;5:CD000214.
    1. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274(9):700–5. doi: 10.1001/jama.1995.03530090032018.
    1. Stacey D, Hill S. Patient-direct and patient-mediated KT interventions. In: Straus S, Tetroe J, Graham ID, editors. Knowledge translation in health care: moving from evidence to practice. Chichester, UK: John Wiley & Sons, Ltd; 2013. pp. 197–211.
    1. Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, et al. Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol. 2006;25(1):91–101. doi: 10.1037/0278-6133.25.1.91.
    1. Zawertailo L, Dragonetti R, Bondy SJ, Victor JC, Selby P. Reach and effectiveness of mailed nicotine replacement therapy for smokers: 6-month outcomes in a naturalistic exploratory study. Tob Control. 2013;22(3):e4. doi: 10.1136/tobaccocontrol-2011-050303.
    1. Cummings KM, Fix B, Celestino P, Carlin-Menter S, O'Connor R, Hyland A. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006;12(1):37–43. doi: 10.1097/00124784-200601000-00009.
    1. Feeley N, Cossette S, Côté J, Héon M, Stremler R, Martorella G, et al. The importance of piloting an RCT intervention. Can J Nurs Res. 2009;41(2):84–99.
    1. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1. doi: 10.1186/1471-2288-10-1.
    1. Canadian Institute for Health Information . Experiences with primary health care in Canada. Ottawa: Canadian Institute for Health Information; 2009.
    1. Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawertailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6987 smokers. Cancer Causes Control. 2011;22(2):167–80. doi: 10.1007/s10552-010-9672-9.
    1. Reid J, Hammond D. Tobacco use in Canada: patterns and trends, 2009 edition (v2) Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo; 2009.
    1. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55. doi: 10.1001/jama.296.1.47.
    1. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63. doi: 10.1001/jama.296.1.56.
    1. Siahpush M, Shaikh RA, McCarthy M, Kessler AS, Tibbits M, Singh GK. Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. BMJ Open. 2015;5(1):e006229. doi: 10.1136/bmjopen-2014-006229.
    1. Statistics Canada . Canadian Community Health Survey (CCHS), 2009–2010. Ottawa: Statistics Canada; 2011.
    1. Collins LM, Schafer JL, Kam C-M. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330–51. doi: 10.1037/1082-989X.6.4.330.
    1. Stata Corp . Stata Statistical Software: Release 12. College Station: StataCorp LP; 2011.
    1. SPSS Inc . SPSS for Windows, Version 16.0. Chicago, IL: SPSS Inc.; 2007.
    1. Statistics Canada . Access to a regular medical doctor, 2013. Ottawa: Statistics Canada; 2014.
    1. Birnbaum MH. Human research and data collection via the Internet. Annu Rev Psychol. 2004;55:803–32. doi: 10.1146/annurev.psych.55.090902.141601.
    1. Abroms LC, Ahuja M, Kodl Y, Thaweethai L, Sims J, Winickoff JP, et al. Text2Quit: results from a pilot test of a personalized, interactive mobile health smoking cessation program. J Health Commun. 2012;17(suppl 1):44–53. doi: 10.1080/10810730.2011.649159.
    1. Statistics Canada . Canadian Internet use survey, 2012. Ottawa: Statistics Canada; 2013.
    1. Statistics Canada . Rates of Internet use, by age group, selected years. Ottawa: Statistics Canada; 2009.
    1. Cunningham JA, Leatherdale ST, Selby PL, Tyndale RF, Zawertailo L, Kushnir V. Randomized controlled trial of mailed nicotine replacement therapy to Canadian smokers: study protocol. BMC Public Health. 2011;11(1):741. doi: 10.1186/1471-2458-11-741.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner